TRPC7 and neoplasm: Furthermore, considering that there is a co-activation mechanism of TRPC3 and TRPC7 protein [42] and the expression of these two genes is negatively correlated in tumor tissues, we guess that the overlapping small molecule anti-tumor drugs are likely to be agonists of TRPC7 protein and inhibitors of TRPC3 protein.